1. Traunmüller F, Popovic M, Konz KH, Vavken P, Leithner A, Joukhadar C. A reappraisal of current dosing strategies for intravenous fosfomycin in children and neonates. Clin Pharmacokinet. 2011 Aug;50(8):493-503.
2. Traunmüller F, Popovic M, Konz KH, Smolle-Jüttner FM, Joukhadar C. Efficacy and safety of current drug therapies for invasive aspergillosis. Pharmacology. 2011;88(3-4):213-24. Epub 2011 Oct 6.
3. Traunmüller F, Schintler MV, Spendel S, Popovic M, Mauric O, Scharnagl E, Joukhadar C. Linezolid concentrations in infected soft tissue and bone following repetitive doses in diabetic patients with bacterial foot infections. Int J Antimicrob Agents. 2010 Jul;36(1):84-6. Epub 2010 Apr 24.
4. Kovar FM, Marsik CL, Joukhadar C, Perkmann T, Haslacher H, Schickbauer T, Kyrle PA, Wagner OF, Endler G. Coagulation factor VIII levels are associated with long-term survival - interactions with gender in a large hospital-based cohort. Wien Klin Wochenschr. 2010 Jun;122(11-12):334-40. Epub 2010 Jun 25.
5. Topp H, Hochfeld O, Bark S, Grossmann M, Joukhadar C, Westphal M, Straatsma H, Rothenburger M. Glycerophosphate does not interact with components of parenteral nutrition. Pharmacology. 2011;88(1- 2):114-20. Epub 2011 October 4.
6. Khadzhynov D, Slowinski T, Lieker I, Spies C, Puhlmann B, König T, Uhrig A, Eggers K, Neumayer HH, Traunmüller F, Joukhadar C, Peters H. Plasma pharmacokinetics of daptomycin in critically ill patients with renal failure and undergoing CVVHD. Int J Clin Pharmacol Ther. 2011 Nov;49(11):656-65.
7. Topp H, Hochfeld O, Bark S, Grossmann M, Joukhadar C, Westphal M, Straatsma H, Rothenburger M. Glycerophosphate is interchangeable with inorganic phosphate in terms of safety and serum pharmacokinetics. Pharmacology. 2011 Oct 4;88(3-4):193-200. Epub 2011 October 4.
8. Mauric O, Thallinger C, Kugler SA, Joukhadar SM, Kovar FM, Konz KH, Graninger W, Joukhadar C. The ability of fluconazole to penetrate into ventilated, healthy and inflamed lung tissue in a model of severe sepsis in rats. Pharmacology. 2011;87(3-4):130-4. Epub 2011 February 10.
9. Lindemann J, Kugler SA, Matzi V, Porubsky C, Maier A, Dittrich P, Graninger W, Smolle-Jüttner FM, Joukhadar C. High extracellular levels of cefpirome in unaffected and infected lung tissue of patients. J Antimicrob Chemother. 2011 Jan;66(1):160-4. Epub 2010 November 16.
10. Kovar FM, Marsik CL, Joukhadar C, Perkmann T, Haslacher H, Schickbauer T, Kyrle PA, Wagner OF, Endler G. Coagulation factor VIII levels are associated with long-term survival – intersections with gender in a large hospital-based cohort. Wien Klin Wochenschr. 2010 Jun;122(11-12):334-40. Epub 2010 June 25.
11. Traunmüller F, Mauric O, Popovic M, Joukhadar C. Rapid and sensitive determination of the antibiotic linezolid in low plasma volumes by high-performance liquid chromatography. J Chromatogr Sci. 2010 May-Jun;48(5):325-7.
12. Traunmüller F, Schintler MV, Spendel S, Popovic M, Mauric O, Scharnagl E, Joukhadar C. Linezolid concentrations in infected soft tissue and bone following repetitive doses in diabetic patients with bacterial foot infections. Int J Antimicrob Agents. 2010 Jul;36(1):84-6. Epub 2010 April 24.
13. Traunmüller F, Schintler MV, Metzler J, Spendel S, Mauric O, Popovic M, Konz KH, Scharnagl E, Joukhadar C. Soft tissue and bone penetration abilities of daptomycin in diabetic patients with bacterial foot infections. J Antimicrob Chemother. 2010 Jun;65(6):1252-7. Epub 2010 April 7.
14. Matzi V, Lindemann J, Porubsky C, Kugler SA, Maier A, Dittrich P, Smolle-Jüttner FM, Joukhadar C. Extracellular concentrations of fosfomycin in lung tissue of septic patients. J Antimicrob Chemother. 2010 May;65(5):995-8. Epub 2010 March 12.
15. Kielstein JT, Eugbers C, Bode-Boeger SM, Martens-Lobenhoffer J, Haller H, Joukhadar C, Traunmüller F, Knitsch W, Hafer C, Burkhardt O. Dosing of daptomycin in intensive care unit patients with acute kidney injury undergoing extended dialysis – a pharmacokinetic study. Nephrol Dial Transplant. 2010 May;25(5):1537-41. Epub 2009 December 22.
16. Joukhadar C, Pillai S, Wennersten C, Moellering RC Jr, Eliopoulos GM. Lack of bactericidal antagonism or synergism in vitro between oxacillin and vancomycin against methicillin-susceptible strains of Staphylococcus aureus. Antimicrob Agents Chemother. 2010 Feb;54(2):773-7. Epub 2009 November 23.
17. Kovar FM, Marsik CL, Jilma B, Mannhalter C, Joukhadar C, Wagner OF, Endler G. The inflammatory response is influenced by FXIII VAL 34 LEU polymorphism in a human LPS model. Wien Klin Wochenschr. 2009;121(15-16):515-9.
18. Schintler MV, Traunmüller F, Metzler J, Kreuzwirt G, Spendel S, Mauric O, Popovic M, Scharnagl E, Joukhadar C. High fosfomycin concentrations in bone and peripheral soft tissue in diabetic patients presenting with bacterial foot infection. J Antimicrob Chemother. 2009 Sep;64(3):574-8. Epub 2009 July 3.
19. Khadzhynov D, Joukhadar C, Peters H. Plasma and peritoneal dialysate levels during daptomycin therapy for peritonitis. Am J Kidney Dis. 2009 May;53(5):911-2.
20. Traunmüller F, Fille M, Thallinger C, Joukhadar C. Multiple-dose pharmacokinetics of telithromycin in peripheral soft tissues. Int J Antimicrob Agents. 2009 Jul;34(1):72-5. Epub 2009 April 19.
21. Joukhadar C, Thallinger C, Pöppl W, Kovar F, Konz KH, Joukhadar SM, Traunmüller F. Concentrations of voriconazole in healthy and inflamed lung in rats. Antimicrob Agents Chemother. 2009 Jun;53(6):2684-6. Epub 2009 Mar 30.
22. Traunmüller F, Thallinger C, Hausdorfer J, Lambers C, Tzaneva S, Kampitsch T, Endler G, Joukhadar C. Tigecycline has no effect on cytokine release in an ex vivo endotoxin model of human whole blood. Int J Antimicrob Agents. 2009 Jun;33(6):583-6. Epub 2009 January 25.
23. Thallinger C, Skorjanec S, Soleiman A, Tzaneva S, Griss J, Rous W, Poeppl W, Weinlich G, Karimian-Teherani D, Joukhadar C. Orally administered rapamycin, dacarbazine or both for treatment of human melanoma evaluated in severe combined immunodeficiency mice. Pharmacology. 2008;82(3):233-8. Epub 2008 September 23.
24. Burklein D, Heyn J, Kirchhoff C, Ozimek A, Traunmuller F, Joukhadar C, Rothenburger M, Mutschler W, Heindl B. Analysis of plasma and peritoneal fluid concentrations of daptomycin in a patient with Enterococcus faecium peritonitis. Int J Antimicrob Agents. 2008 Oct;32(4):369-71.
25. Ehrlich HJ, Müller M, Oh HM, Tambyah PA, Joukhadar C, Montomoli E, Fisher D, Berezuk G, Fritsch S, Löw-Baselli A, Vartian N, Bobrovsky R, Pavlova BG, Pöllabauer EM, Kistner O, Barrett PN; Baxter H5N1 Pandemic Influenza Vaccine Clinical Study Team. A clinical trial of a whole-virus H5N1 vaccine derived from cell culture. N Engl J Med. 2008 Jun 12;358(24):2573-84. Epub 2008 August 13.
26. Sauermann R, Mayer-Helm BX, Petsch M, Popovic M, Thallinger C, Joukhadar C. Is experimental endotoxaemia in humans suitable for simulating antibiotic pharmacokinetics in sepsis and septic shock? A pilot study using the model compound. Int J Antimicrob Agents. 2008 Mar;31(3):291-2. Epub 2007 December 21.
27. Marsik C, Kazemi-Shirazi L, Schickbauer T, Winkler S, Joukhadar C, Wagner OF, Endler G. C-reactive protein and all-cause mortality in a large hospital based cohort. Clin Chem. 2008 Feb;54(2):343-9. Epub 2007 December 21.
28. Stolle LB, Plock N, Joukhadar C, Arpi M, Emmertsen KJ, Buerger C, Riegels-Nielsen P, Kloft C. Pharmacokinetics of linezolid in bone tissue investigated by in vivo microdialysis. Scand J Infect Dis. 2008;40(1):24- 9.
29. Kaehler S, Marsik C, Heinisch B, Thallinger C, Sauermann R, Kazemi- Shirazi L, Wagner O, Joukhadar C. S-Ibuprofen effectively inhibits thromboxane B2 levels and platelet function in an experimental model of lipopolysaccharide-stimulated and non-stimulated whole blood. Pharmacology. 2008;81(2):181-6. Epub 2007 November 28.
30. Thallinger C, Buerger C, Plock N, Kljucar S, Wuenscher S, Sauermann R, Kloft C, Joukhadar C. Effect of severity of sepsis on tissue concentrations of linezolid. J Antimicrob Chemother. 2008 Jan;61(1):173-6. Epub 2007 November 13.
31. Burkhardt O, Joukhadar C, Traunmüller F, Hadem J, Welte T, Kielstein JT. Elimination of daptomycin in a patient with acute renal failure undergoing extended daily dialysis. J Antimicrob Chemother. 2008 Jan;61(1):224-5. Epub 2007 October 26.
32. Thallinger C, Rothenburger M, Marsik C, Wuenscher S, Popovic M, Endler G, Wagner O, Joukhadar C. Daptomycin does not exert immunomodulatory effects in an experimental endotoxin model of human whole blood. Pharmacology. 2008;81(1):57-62. Epub 2007 September 11.
33. Abrahim A, Luurtsema G, Bauer M, Karch R, Lubberink M, Pataraia E, Joukhadar C, Kletter K, Lammertsma AA, Baumgartner C, Müller M, Langer O. Peripheral metabolism of (R)-[(11)C]verapamil in epilepsy patients. Eur J Nucl Med Mol Imaging. 2008 Jan;35(1):116-23. Epub 2007 September 11.
34. Sacher J, Mossaheb N, Spindelegger C, Klein N, Geiss-Granadia T, Sauermann R, Lackner E, Joukhadar C, Müller M, Kasper S. Effects of olanzapine and ziprasidone on glucose tolerance in healthy volunteers. Neuropsychopharmacology. 2008 Jun;33(7):1633-41. Epub 2007 August 22.
35. Plock N, Buerger C, Joukhadar C, Kljucar S, Kloft C. Does linezolid inhibit its own metabolism? - Population pharmacokinetics as a tool to explain the observed nonlinearity in both healthy volunteers and septic patients. Drug Metab Dispos. 2007 Oct;35(10):1816-23. Epub 2007 July 16.
36. Traunmüller F, Zeitlinger M, Zeleny P, Müller M, Joukhadar C. Pharmacokinetics of single- and multiple-dose oral clarithromycin in soft tissues determined by microdialysis. Antimicrob Agents Chemother. 2007 Sep;51(9):3185-9. Epub 2007 July 2.
37. Thallinger C, Werzowa J, Poeppl W, Kovar FM, Pratscher B, Valent P, Quehenberger P, Joukhadar C. Comparison of a treatment strategy combining CCI-779 plus DTIC versus DTIC monotreatment in human melanoma in SCID mice. J Invest Dermatol. 2007 Oct;127(10): 2411-7. Epub 2007 May 17.
38. Langer O, Bauer M, Hammers A, Karch R, Pataraia E, Koepp MJ, Abrahim A, Luurtsema G, Brunner M, Sunder-Plassmann R, Zimprich F, Joukhadar C, Gentzsch S,Dudczak R, Kletter K, Müller M, Baumgartner C. Pharmacoresistance in epilepsy: a pilot PET study with the P- glycoprotein substrate R-[C]verapamil. Epilepsia. 2007 Sep;48(9):1774- 84. Epub 2007 May 1.
39. Chaurasia CS, Müller M, Bashaw ED, Benfeldt E, Bolinder J, Bullock R, Bungay PM, Delange EC, Derendorf H, Elmquist WF, Hammarlund- Udenaes M, Joukhadar C, Kellogg DL Jr, Lunte CE, Nordstrom CH, Rollema H, Sawchuk RJ, Cheung BW, Shah VP, Stahle L, Ungerstedt U, Welty DF, Yeo H. AAPS-FDA workshop white paper: microdialysis principles, application and regulatory perspectives. Pharm Res. 2007 May;24(5):1014-25. Epub 2007 March 27.
40. Chaurasia CS, Müller M, Bashaw ED, Benfeldt E, Bolinder J, Bullock R, Bungay PM, Delange EC, Derendorf H, Elmquist WF, Hammarlund- Udenaes M, Joukhadar C, Kellogg DL Jr, Lunte CE, Nordstrom CH, Rollema H, Sawchuk RJ, Cheung BW, Shah VP, Stahle L, Ungerstedt U, Welty DF, Yeo H. AAPS-FDA workshop white paper: microdialysis principles, application and regulatory perspectives. J Clin Pharmacol. 2007 May;47(5):589-603.
41. Thallinger C, Poeppl W, Pratscher B, Mayerhofer M, Valent P, Tappeiner G, Joukhadar C. CCI-779 plus cisplatin is highly effective against human melanoma in a SCID mouse xenotranplantation model. Pharmacology. 2007;79(4):207-213. Epub 2007 March 22.
42. Sauermann R, Marsik C, Steiner I, Seir K, Civtko T, Zeitlinger M, Wagner O, Joukhadar C. Immunomodulatory effects of fosfomycin in experimental human endotoxemia. Antimicrob Agents Chemother. 2007 May;51(5):1879-81. Epub 2007 March 12.
43. Zeitlinger BS, Zeitlinger M, Leitner I, Muller M, Joukhadar C. Clinical scoring system for the prediction of target site penetration of antimicrobials in patients with sepsis. Clin Pharmacokinet. 2007;46(1):75-83.
44. Zeitlinger MA, Traunmüller F, Abrahim A, Müller MR, Erdogan Z, Müller M, Joukhadar C. A pilot study testing whether concentrations of levofloxacin in interstitial space fluid of soft tissues may serve as a surrogate for predicting its pharmacokinetics in lung. Int J Antimicrob Agents. 2007 Jan;29(1):44-50.
45. Zeitlinger M, Marsik C, Steiner I, Sauermann R, Seir K, Jilma B, Wagner O, Joukhadar C. Immunomodulatory effects of fosfomycin in an endotoxin model in human blood. J Antimicrob Chemother. 2007 Feb; 59(2):219-23. Epub 2006 November 16.
46. Bauer M, Langer O, Dal-Bianco P, Karch R, Brunner M, Abrahim A, Lanzenberger R, Hofmann A, Joukhadar C, Carminati P, Ghirardi O, Piovesan P, Forloni G, Corrado ME, Lods N, Dudczak R, Auff E, Kletter K, Müller M. A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer disease. Clin Pharmacol Ther. 2006 Sep;80(3):216-27.
47. Buerger C, Plock N, Dehghanyar P, Joukhadar C, Kloft C. Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis. Antimicrob Agents Chemother. 2006 Jul;50(7):2455-63.
48. Gattringer R, Meyer B, Heinz G, Guttmann C, Zeitlinger M, Joukhadar C, Dittrich P, Thalhammer F. Single-dose pharmacokinetics of fosfomycin during continuous venovenous haemofiltration. J Antimicrob Chemother. 2006 Aug; 58(2):367-71. Epub 2006 June 16.
49. Traunmüller F, Steiner I, Zeitlinger M, Joukhadar C. Development of a high-performance liquid chromatography method for the determination of caspofungin with amperometric detection and its application to in vitro microdialysis experiments. J Chromatogr B Analyt Technol Biomed Life Sci. 2006 November 7;843(2):142-6. Epub 2006 June 19.
50. Kaehler ST, Steiner IM, Sauermann R, Scheidl H, Mueller M, Joukhadar C. A bioequivalence study of two oral desmopressin tablet formulations. Pharmacology. 2006;77(1):46-52. Epub 2006 April 10.
51. Steiner IM, Kaehler ST, Sauermann R, Rinösl H, Müller M, Joukhadar C. Plasma pharmacokinetics of desmopressin following sublingual administration: an exploratory dose-escalation study in healthy male volunteers. Int J Clin Pharmacol Ther. 2006 Apr;44(4):172-9.
52. Islinger F, Dehghanyar P, Sauermann R, Bürger C, Kloft C, Müller M, Joukhadar C. The effect of food on plasma and tissue concentrations of linezolid after multiple doses. Int J Antimicrob Agents. 2006 Feb;27(2):108-12. Epub 2006 January 4.
53. Thallinger C, Urbauer E, Lackner E, Graselli U, Kostner K, Wolzt M, Joukhadar C. The ability of statins to protect low-density lipoprotein from oxidation in hypercholesterolemic patients. Int J Clin Pharmacol Ther. 2005 Dec;43(12):551-7.
54. Schwalbe O, Buerger C, Plock N, Joukhadar C, Kloft C. Urea as an endogenous surrogate in human microdialysis to determine relative recovery of drugs: analytics and applications. J Pharm Biomed Anal. 2006 Apr 11;41(1):233-9. Epub 2005 December 20.
55. Zeitlinger M, Müller M, Joukhadar C. Lung microdialysis-a powerful tool for the determination of exogenous and endogenous compounds in the lower respiratory tract (mini-review). AAPS J. 2005 Oct 22;7(3):E600-8. Review.
56. Langer O, Karch R, Müller U, Dobrozemsky G, Abrahim A, Zeitlinger M, Lackner E, Joukhadar C, Dudczak R, Kletter K, Müller M, Brunner M. Combined PET and microdialysis for in vivo assessment of intracellular drug pharmacokinetics in humans. J Nucl Med. 2005 Nov;46(11):1835- 41.
57. Bauer E, Derfler K, Joukhadar C, Druml W. Citrate kinetics in patients receiving long-term hemodialysis therapy. Am J Kidney Dis. 2005 Nov;46(5):903-7.
58. Sauermann R, Karch R, Langenberger H, Kettenbach J, Mayer-Helm B, Petsch M, Wagner C, Sautner T, Gattringer R, Karanikas G, Joukhadar C. Antibiotic abscess penetration: fosfomycin levels measured in pus and simulated concentration-time profiles. Antimicrob Agents Chemother. 2005 Nov;49(11):4448-54.
59. Marsik C, Jilma B, Joukhadar C, Mannhalter C, Wagner O, Endler G. The Toll-Like receptor 4 Asp299Gly and Thr399Ile polymorphisms influence the late inflammatory response in human endotoxemia. Clin Chem. 2005 Nov;51(11):2178-80.
60. Kulemann V, Bauer M, Graninger W, Joukhadar C. Safety and potential of drug interactions of caspofungin and voriconazole in multimorbid patients. Pharmacology. 2005 Dec;75(4):165-178. Epub 2005 September 28. Review.
61. Joukhadar C, Dehghanyar P, Traunmuller F, Sauermann R, Mayer-Helm B, Georgopoulos A, Müller M. Increase of microcirculatory blood flow enhances penetration of ciprofloxacin into soft tissue. Antimicrob Agents Chemother. 2005 Oct;49(10):4149-53.
62. Ziegler S, Kostner K, Thallinger C, Bur A, Brunner M, Wolzt M, Joukhadar C. Wine ingestion has no effect on lipid peroxidation products. Pharmacology. 2005 Nov;75(3):152-6. Epub 2005 September 13.
63. Zeitlinger MA, Erovic BM, Sauermann R, Georgopoulos A, Müller M, Joukhadar C. Plasma concentrations might lead to overestimation of target site activity of piperacillin in patients with sepsis. J Antimicrob Chemother. 2005 Oct;56(4):703-8. Epub 2005 August 24.
64. Petsch M, Mayer-Helm BX, Sauermann R, Joukhadar C, Kenndler E. Determination of fosfomycin in pus by capillary zone electrophoresis. J Chromatogr A. 2005 July 15;1081(1):55-9.
65. Traunmüller F, Gattringer R, Zeitlinger MA, Graninger W, Müller M, Joukhadar C. Determination of telithromycin in human plasma and microdialysates by high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 August 5;822(1- 2):133-6.
66. Dehghanyar P, Bürger C, Zeitlinger M, Islinger F, Kovar F, Müller M, Kloft C, Joukhadar C. Penetration of linezolid into soft tissues of healthy volunteers after single and multiple doses. Antimicrob Agents Chemother. 2005 Jun;49(6):2367-71.
67. Bur A, Joukhadar C, Klein N, Herkner, Mitulovic G, Schmid R, Agneter E, Müller M, Brunner M. Effect of exercise on transdermal nicotine release in healthy habitual smokers. Int J Clin Pharmacol Ther. 2005 May;43(5):239-43.
68. Stetina PM, Madai B, Kulemann V, Kirch W, Joukhadar C. Pharmacokinetics of scopolamine in serum and subcutaneous adipose tissue in healthy volunteers. Int J Clin Pharmacol Ther. 2005 Mar;43(3):134-9.
69. Langer O, Brunner M, Zeitlinger M, Ziegler S, Müller U, Dobrozemsky G, Lackner E, Joukhadar C, Mitterhauser M, Wadsak W, Minar E, Dudczak R, Kletter K, Müller M. In vitro and in vivo evaluation of [18F]ciprofloxacin for the imaging of bacterial infections with PET Eur J Nucl Med Mol Imaging. 2005 Feb;32(2):143-50. Epub 2004 September 4.
70. Sauermann R, Delle-Karth G, Marsik C, Steiner I, Zeitlinger M, Mayer- Helm BX, Georgopoulos A, Müller M, Joukhadar C. Pharmacokinetics and pharmacodynamics of cefpirome in subcutaneous adipose tissue of septic patients. Antimicrob Agents Chemother. 2005 Feb;49(2):650- 5.
71. Frossard M, Blank D, Joukhadar Ch, Bayegan K, Schmid R, Luger A, Müller M. Interstitial glucose in skeletal muscle of diabetic patients during an oral glucose tolerance test. Diabet Med. 2005 Jan;22(1):56- 60.
72. Gattringer R, Urbauer E, Traunmüller F, Zeitlinger M, Dehghanyar P, Zeleny P, Graninger W, Müller M, Joukhadar C. Pharmacokinetics of telithromycin in plasma and soft tissues after single-dose administration to healthy volunteers. Antimicrob Agents Chemother. 2004 Dec;48(12):4650-3.
73. Islinger F, Bouw R, Stahl M, Lackner E, Zeleny P, Brunner M, Müller M, Eichler HG, Joukhadar C. Concentrations of gemifloxacin at the target site after a single oral dose in healthy volunteers. Antimicrob Agents Chemother. 2004 Nov;48(11):4246-9.
74. Zeitlinger MA, Sauermann R, Traunmüller F, Georgopoulos A, Müller M, Joukhadar C. Impact of plasma protein binding on antimicrobial activity using time-killing curves. J Antimicrob Chemother. 2004 Nov;54(5):876-80. Epub 2004 October 7.
75. Petsch M, Mayer-Helm BX, Sauermann R, Joukhadar C, Kenndler E. Capillary electrophoresis analysis of fosfomycin in biological fluids for clinical pharmacokinetic studies. Electrophoresis. 2004 Jul;25(14):2292- 8.
76. Bellmann R, Kuchling G, Dehghanyar P, Zeitlinger M, Minar E, Mayer BX, Müller M, Joukhadar C. Tissue pharmacokinetics of levofloxacin in human soft tissue infections. Br J Clin Pharmacol. 2004 May;57(5):563- 8.
77. Pfausler B, Spiss H, Dittrich P, Zeitlinger M, Schmutzhard E, Joukhadar C. Concentrations of fosfomycin in the cerebrospinal fluid of neurointensive care patients with ventriculostomy-associated ventriculitis. J Antimicrob Chemother. 2004 May;53(5):848-52. Epub 2004 March 31.
78. Steiner IM, Langenberger H, Marsik C, Mayer BX, Fischer M, Georgopoulos A, Müller M, Heinz G, Joukhadar C. Effect of norepinephrine on cefpirome tissue concentrations in healthy subjects. J Antimicrob Chemother. 2004 Mar;53(3):506-11. Epub 2004 January 28.
79. Endler G, Marsik C, Joukhadar C, Marculescu R, Mayr F, Mannhalter C, Wagner OF, Jilma B. The interleukin-6 G(-174)c promoter polymorphism does not determine plasma interleukin-6 concentrations in experimental endotoxemia in humans. Clin Chem. 2004 Jan;50(1):195-200.
80. Sauermann R, Zeitlinger M, Erovic BM, Marsik C, Georgopoulos A, Müller M, Brunner M, Joukhadar C. Pharmacodynamics of piperacillin in severely ill patients evaluated by using a PK/PD model. Int J Antimicrob Agents. 2003 Dec;22(6):574-578.
81. Zeitlinger MA, Dehghanyar P, Mayer BX, Schenk BS, Neckel U, Heinz G, Georgopoulos A, Müller M, Joukhadar C. Relevance of soft-tissue penetration by levofloxacin for target site bacterial killing in patients with sepsis. Antimicrob Agents Chemother. 2003 Nov;47(11):3548-53.
82. Joukhadar C, Schenk B, Kaehler ST, Kollenz CJ, Bauer P, Müller M, Eichler HG. A replicate study design for testing bioequivalence: a case study on two desmopressin nasal spray preparations. Eur J Clin Pharmacol. 2003 Nov;59(8-9):631-636. Epub 2003 October 17.
83. Buerger C, Joukhadar C, Muller M, Kloft C. Development of a liquid chromatography method for the determination of linezolid and its application to in vitro and human microdialysis samples. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 October 25;796(1):155-164.
84. Kramer L, Bauer E, Joukhadar C, Strobl W, Gendo A, Madl C, Gangl A. Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients. Crit Care Med. 2003 Oct;31(10):2450-5.
85. Joukhadar C, Stass H, Müller-Zellenberg U, Lackner E, Kovar F, Minar E, Müller M. Penetration of moxifloxacin into healthy and inflamed subcutaneous adipose tissues in humans. Antimicrob Agents Chemother. 2003 Oct;47(10):3099-103.
86. Urbauer E, Joukhadar C. [Non-lipid effects of statins: myth or fact?] Wien Med Wochenschr. 2003;153(11-12):244-9. Review. German.
87. Zeitlinger MA, Marsik C, Georgopoulos A, Müller M, Heinz G, Joukhadar C. Target site bacterial killing of cefpirome and fosfomycin in critically ill patients. Int J Antimicrob Agents. 2003 Jun;21(6):562-7.
88. Buerger C, Joukhadar C, Müller M, Kloft C. [Individualized therapy through monitoring of drug concentration in the biophase]. Med Monatsschr Pharm. 2003 May;26(5):158-9. Review. German.
89. Priglinger U, Delle Karth G, Geppert A, Joukhadar C, Graf S, Berger R, Hülsmann M, Spitzauer S, Pabinger I, Heinz G. Prophylactic anticoagulation with enoxaparin: Is the subcutaneous route appropriate in the critically ill? Crit Care Med. 2003 May;31(5):1405-9.
90. Joukhadar C, Klein N, Dittrich P, Zeitlinger M, Geppert A, Skhirtladze K, Frossard M, Heinz G, Müller M. Target site penetration of fosfomycin in critically ill patients. J Antimicrob Chemother. 2003 May;51(5):1247- 52. Epub 2003 March 28.
91. Herkner H, Klein N, Joukhadar C, Lackner E, Langenberger H, Frossard M, Bieglmayer C, Wagner O, Roden M, Müller M. Transcapillary insulin transfer in human skeletal muscle. Eur J Clin Invest. 2003 Feb;33(2):141-6.
92. Jilma B, Joukhadar C, Derhaschnig U, Rassoul F, Richter V, Wolzt M, Dorner GT, Petternel V, Wagner OF. Levels of adhesion molecules do not decrease after 3 months of statin therapy in moderate hypercholesterolaemia. Clin Sci (Lond). 2003 Feb;104(2):189-93.
93. Joukhadar C, Klein N, Mayer BX, Kreischitz N, Delle-Karth G, Palkovits P, Heinz G, Müller M. Plasma and tissue pharmacokinetics of cefpirome in patients with sepsis. Crit Care Med. 2002 Jul;30(7):1478- 82.
94. Herkner H, Müller MR, Kreischitz N, Mayer BX, Frossard M, Joukhadar C, Klein N, Lackner E, Müller M. Closed-chest microdialysis to measure antibiotic penetration into human lung tissue. Am J Respir Crit Care Med. 2002 Jan 15;165(2):273-76.
95. Joukhadar C, Klein N, Frossard M, Minar E, Stass H, Lackner E, Herrmann M, Riedmüller E, Müller M. Angioplasty increases target site concentrations of ciprofloxacin in patients with peripheral arterial occlusive disease. Clin Pharmacol Ther. 2001 Dec; 70(6):532-9.
96. Joukhadar C, Klein N, Mader RM, Schrolnberger C, Rizovski B, Heere- Ress E, Pehamberger H, Strauchmann N, Jansen B, Muller M. Penetration of dacarbazine and its active metabolite 5- aminoimidazole-4-carboxamide into cutaneous metastases of human malignant melanoma. Cancer. 2001 Oct 15;92(8):2190-6. Erratum in Cancer 2002 Jun 1;94(11):3072.
97. Joukhadar C, Derendorf H, Müller M. Microdialysis. A novel tool for clinical studies of antiinfective agents. Eur J Clin Pharmacol. 2001 June; 57(3):211-9. Review.
98. Joukhadar C, Herranz U, Pernerstorfer T, Assandri A, Klein N, Schrolnberger C, Lackner E, Eichler HG, Müller M. Pharmacokinetics of emedastine difumarate, a new anti-histamic agent in patients with renal impairment. Eur J Clin Pharmacol. 2001 Mar; 56(12):905-10.
99. Joukhadar C, Frossard M, Mayer BX, Brunner M, Klein N, Siostrzonek P, Eichler HG, Müller M. Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock. Crit. Care Med. 2001 Feb;29(2):385-91.
100. Joukhadar C, Klein N, Prinz M, Schrolnberger C, Vukovich T, Wolzt M, Schmetterer L, Dorner G. Similar effects of atorvastatin, simvastatin and pravastatin on thrombogenic and inflammatory parameters in patients with hypercholesterolemia. Thromb and Haemost. 2001 Jan;85(1):47-51.
101. Delacher S, Derendorf H, Hollenstein U, Brunner M, Joukhadar C, Hofmann S, Georgopoulos A, Eichler HG, Müller M. A combined in vivo pharmacokinetic-in vitro pharmacodynamic approach to simulate target site pharmacodynamics of antibiotics in humans. J Antimicrob Chemother. 2000 Nov;46(5):733-9.
102. Frossard M, Joukhadar C, Erovic BM, Dittrich P, Mrass PE, Van Houte M, Burgmann H, Georgopoulos A, Müller M. Distribution and antimicrobial activity of fosfomycin in the interstitial fluid of human soft tissues. Antimicrob Agents and Chemther. 2000 Oct;44(10):2728- 32.
103. Brunner M, Joukhadar C, Schmid R, Erovic B, Eichler HG, Müller M. Validation of urea as an endogenous reference compound for the in vivo calibration of microdialysis probes. Life Sci. 2000 July 14;67(8):977-84.
104. Frossard M, Joukhadar C, Steffen G, Brunner M, Schmid R, Eichler HG, Müller M. Paracrine effects of angiotensin-converting-enzyme and angiotensin-II-receptor-inhibition on transcapillary glucose transport in humans. Life Sci. 2000; 66(10):PL147-54.
105. Müller M, Brunner B, Hollenstein H, Joukhadar C, Schmid R, Minar E, Ehringer H, Eichler HG. Penetration of ciprofloxacin into the interstitial space of inflamed foot lesions in non-insulin-dependent diabetes mellitus patients. Antimicrob Agents Chemther. 1999 Aug;43(8):2056- 8.
106. Abrahim A., Angelberger P, Kletter K, Müller M, Joukhadar C, Erker T, Langer O: Synthesis of fluorine-18-labelled 5- and 6-fluoro-2- pyridinamine. J Labelled Compd Rad. 2006 March;49(4):345-356.
107. Steiner I, Müller M, Joukhadar C. Antibiotika im schwer erreichbaren Kompartiment – Beträge aus Grundlagenmedizin und Klinik. Chemother J. 2004 Oct;13(5):195-202, German.
108. Neckel U, Joukhadar C, Frossard M, Jäger W, Müller M, Mayer BX. Simultaneous determination of levofloxacin and ciprofloxacin in microdialysates and plasma by HPLC. Anal Chim Acta. 2002 July;463(2):199-206.
109. Kulemann V, Bauer M, Graninger W, Joukhadar C. Potential of drug interactions of voriconazole and caspofungin. Wiener Klinische Wochenschrift Magazin 2005;5:24-34.
110. Sauermann R, Müller M, Joukhadar C. Die Penetration von Antibiotika in das schwer erreichbare Kompartiment. Chemotherapie Journal. 2005;14(3):74-8.
111. Bauer MM, Gattringer R, Joukhadar C. Fosfomycin im schwer erreichbaren Kompartiment. Antibiotika Monitor. 2005;21(1/2):2-7. German.
112. Joukhadar C, Kulemann V. Mikrodialyse: Bestimmung der Arzneistoff- konzentration im Zielgewebe. Universum Innere Medizin. 2004 (05):16. German.
113. Zeitlinger M, Graninger W, Joukhadar C. Pharmacokinetics of the macrolides azithromycin, clarithromycin and roxithromycin in plasma and tissue – are there significant differences? Wiener Klinische Wochenschrift. 2004 (11-12a):18-24.
1. Traunmüller F, Popovic M, Konz KH, Smolle-Jüttner FM, Joukhadar C. Efficacy and safety of current drug therapies for invasive aspergillosis. Pharmacology. 2011;88(3-4):213-224. Epub 2011 Oct. 6. Review.
2. Traunmüller F, Popovic M, Konz KH, Vavken P, Leithner A, Joukhadar C. A reappraisal of current dosing strategies for intravenous fosfomycin in children and neonates. Clin Pharmacokinet. 2011 Aug 1;50(8):493-503. Review.
3. Popovic M, Steinort D, Pillai S, Joukhadar C. Fosfomycin: an old, new friend? Eur J Clin Microbiol Infect Dis. 2010 Feb;29(2):127-42. Epub 2009 Nov 14. Review.
4. Sauermann R, Rothenburger M, Graninger W, Joukhadar C. Daptomycin: A review 4 years after first approval. Pharmacology. 2008;81(2):79-91. Epub 2007 October 16. Review.
5. Joukhadar C, Müller M. Microdialysis: current applications in clinical pharmacokinetic studies and its potential role in the future. Clin Pharmacokinet. 2005;44(9):895-913. Review.
6. Wagner C, Graninger W, Presterl E, Joukhadar C. The echinocandins: comparison of their pharmacokinetics, pharmacodynamics and clinical applications. Pharmacology. 2006;78(4):161-177. Epub 2006 October 17. Review.
7. Thallinger C, Joukhadar C. [Cytochrom-P450 mediated drug interactions caused by antibiotics]. Wien Med Wochenschr. 2006 Sep;156(17-18):508-14. Review. German.
8. Wagner C, Sauermann R, Joukhadar C. Principles of antibiotic penetration into abscess fluid. Pharmacology 2006;78(1):1-10. Epub 2006 July 19. Review.
1. Joukhadar C, Müller M. Good Clinical Practice – friend or foe? John Wiley & Sons Ltd. 2007:377-385.
2. Thallinger C., Joukhadar C. The journey of a drug to the target site: what is decisive? Anaesthesia Pain Intensive Care and Emergency Medicine – APICE Springer Verlag Italien 2005: 167-175.
3. Kulemann V., Joukhadar C. The pharmacokinetics and pharmacodynamics of antimicrobial agents in intensive care unit patients as assessed by microdialysis. Anaesthesia Pain Intensive Care and Emergency Medicine – APICE Springer Verlag Italien 2005:177-183.
4. Islinger F., Joukhadar C. Tissue pharmacokinetics of antimicrobial agents in septic patients. Microdialysis - Monitoring Tissue Chemistry in Intensive Care Medicine: Experimental Results and Clinical Application of Biochemical Tissue Monitoring in Critical Illness. Pabst Science Publishers 2004:109-116.
5. Thallinger C, Joukhadar C. Antibiotika und Sepsis: Pharmakokinetische Betrachtungen – Grundlagen. Wiener klinisches Magazin 2006;-(6):18. German.
6. Thallinger C, Joukhadar C. Antibiotika und Sepsis. Wiener klinisches Magazin 2007;-(3):20. German.
7. Joukhadar C, Thallinger C. MRSA in Haut und Weichgewebe. Universum Innere Medizin 2007, 01/17:14-15. German.
8. Thallinger C. Joukhadar C. Arzneimittelwechselwirkungen und Anti- infektiologika: Verhängnisvolle Interaktionen. Universum Innere Medizin. 2005, 07:22-23. German.
9. Thallinger C, Joukhadar C. Clopidogrel und Statine: Freund und Freud oder Feind und Leid? Der Monitor 2006, 6:14-17. German.
10. Thallinger C, Joukhadar C. Mikrodialyse – eine Revolution auf dem Gebiet der Pharmakologie. Antibiotika Monitor 2005;4/5: 91-95. German.